Showing results (1-10 of 84) with videos related to
Sort By:
Pageof 9
Methods in Molecular Biology (Clifton, N.J.)|October 12, 2024
Quantitative Intravital Calcium Imaging in Mouse KidneyAndreja Figurek, Nevena Jankovic, Andrew M HallNature Communications|February 18, 2026
Pyrimidinergic calcium signaling links tubular metabolism to fibrosis in kidney diseaseAndreja Figurek, Nevena Jankovic, Sarah Kollar, et al.American Journal of Physiology. Renal Physiology|June 23, 2020
Quantitative intravital Ca<sup>2+</sup> imaging maps single cell behavior to kidney tubular structureJoana R Martins, Dominik Haenni, Milica Bugarski, et al.International Urology and Nephrology|July 22, 2018
Is serum sclerostin a marker of atherosclerosis in patients with chronic kidney disease-mineral and bone disorder?Andreja Figurek, Goce SpasovskiNature Communications|March 10, 2026
Heterogeneity in lysosomal dynamics and metabolic functions along the kidney proximal tubuleMonika Kaminska, Imene B Sakhi, Nevena Jankovic, et al.Toxins|February 29, 2020
Should We Consider the Cardiovascular System While Evaluating CKD-MBD?Merita Rroji, Andreja Figurek, Goce SpasovskiCells|June 2, 2021
The Complexity of FGF23 Effects on Cardiomyocytes in Normal and Uremic MilieuAndreja Figurek, Merita Rroji, Goce SpasovskiExpert Review of Proteomics|August 12, 2024
Advancing kidney transplant outcomes: the role of urinary proteomics in graft function monitoring and rejection detectionMerita Rroji, Andreja Figurek, Goce SpasovskiDiagnostics (Basel, Switzerland)|March 29, 2023
Proteomic Approaches and Potential Applications in Autosomal Dominant Polycystic Kidney Disease and Fabry DiseaseMerita Rroji, Andreja Figurek, Goce SpasovskiInternational Urology and Nephrology|October 16, 2019
Sclerostin: a new biomarker of CKD-MBDAndreja Figurek, Merita Rroji, Goce SpasovskiPageof 9